Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Aprogen Biologics Inc.

Market Cap 33.78B 22.33M 19.25M 17.72M 16.62M 31.22M 2.11B 31.53M 209M 81.81M 1.03B 83.81M 82.03M 3.58B P/E Ratio 2024
-0.79x
P/E Ratio 2025 -0.6x
Enterprise Value 211B 139M 120M 111M 104M 195M 13.18B 197M 1.31B 511M 6.45B 523M 512M 22.33B EV / Sales 2024
3.66x
EV / Sales 2025 3.82x
Free-Float
95.86%
Yield 2024 *
-
Yield 2025 -
1 day-0.39%
1 week-0.77%
Current month-18.96%
1 month-36.03%
3 months-37.13%
6 months-71.21%
Current year-67.05%
1 week 2,490
Extreme 2490
2,880
1 month 2,490
Extreme 2490
4,440
Current year 2,490
Extreme 2490
8,490
1 year 2,490
Extreme 2490
10,725
3 years 2,490
Extreme 2490
108,600
5 years 2,490
Extreme 2490
204,750
10 years 2,490
Extreme 2490
1,000,000
Manager TitleAgeSince
Chief Executive Officer 63 2023-10-12
Chief Executive Officer 70 2012-03-31
Sales & Marketing 62 -
Director TitleAgeSince
Director/Board Member 70 2012-03-31
Director/Board Member 65 2020-03-22
Director/Board Member 63 2023-10-12
Date Insider Type Main position Quantity % Market Cap.
24-06-27Fiscal year

Executive/Senior Manager

6,183 0.0046%
24-06-27Fiscal year

Executive/Senior Manager

6,183 0.0046%
24-06-27Fiscal year 11,846 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%-0.77%-74.09%-95.52% 22.33M
-0.32%-1.72%+37.83%+148.79% 1,007B
-2.16%+1.51%+50.01%+43.93% 567B
-2.70%-0.66%+15.97%+63.07% 392B
0.00%+1.05%+20.91%+18.37% 328B
-0.17%+1.22%+24.33%+32.02% 277B
+0.48%-2.77%+22.52%+12.44% 275B
+0.16%+5.84%-42.73%-48.31% 196B
-1.31%+1.39%+18.74%+53.45% 189B
-1.03%-2.97%+13.02%+57.34% 154B
Average -0.66%+0.12%+8.65%+28.56% 338.61B
Weighted average by Cap. -0.59%-0.03%+26.49%+67.11%

Financials

2024 2025
Net sales 67.38B 44.54M 38.39M 35.33M 33.14M 62.26M 4.21B 62.88M 418M 163M 2.06B 167M 164M 7.13B 73.23B 48.41M 41.72M 38.4M 36.02M 67.66M 4.57B 68.34M 454M 177M 2.24B 182M 178M 7.75B
Net income -105B -69.4M -59.81M -55.05M -51.64M -97M -6.56B -97.97M -651M -254M -3.21B -260M -255M -11.11B -170B -113M -97.05M -89.32M -83.79M -157M -10.64B -159M -1.06B -412M -5.21B -423M -414M -18.03B
Net Debt 116B 76.48M 65.92M 60.67M 56.91M 107M 7.23B 108M 717M 280M 3.54B 287M 281M 12.25B 177B 117M 101M 92.9M 87.15M 164M 11.07B 165M 1.1B 429M 5.42B 439M 430M 18.76B
Logo Aprogen Biologics Inc.
Aprogen Biologics Inc, formerly Aprogen Pharmaceuticals Inc, is a Korea-based company principally engaged in the pharmaceutical business. The Company operates its business through two segments. The Medicine Business segment is engaged in the manufacture and sale of central nervous system drugs, autonomic agents, arteriosclerosis agents, metabolic agents, circulatory system drugs, biopharmaceuticals and others. The Segment is also engaged in the manufacture and sale of cosmetics such as skin moisturizers and others. The Gaming Business segment is engaged in the development and operation of role-playing games (RPGs).
Employees
391
Date Price Change Volume
26-06-15 2,565.00 -0.39% 72,500
26-06-12 2,575.00 +3.00% 37,369
26-06-11 2,500.00 -1.96% 61,579
26-06-10 2,550.00 -2.30% 88,572
26-06-09 2,610.00 +0.97% 67,007
  1. Stock Market
  2. Stocks
  3. A003060 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!